These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6332978)

  • 1. Analytical DNA flow cytometric analysis of deoxyadenosine toxicity in cultured human leukemic lymphoblasts.
    Fox RM; Tripp EH; Taylor IW
    Mol Pharmacol; 1984 Sep; 26(2):388-94. PubMed ID: 6332978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyadenosine induced G1 phase arrest in leukemic T cells.
    Fox RM; Tripp EH; Taylor IW
    Adv Exp Med Biol; 1984; 165 Pt B():333-8. PubMed ID: 6609539
    [No Abstract]   [Full Text] [Related]  

  • 4. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts.
    Kefford RF; Fox RM; McCairns E; Fahey D; Muscat GE; Rowe PB
    Cancer Res; 1983 May; 43(5):2252-7. PubMed ID: 6187447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Nodzenski E
    Exp Cell Res; 1988 Dec; 179(2):417-28. PubMed ID: 3056732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
    Hershfield MS; Kredich NM
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.
    Mann GJ; Fox RM
    J Clin Invest; 1986 Nov; 78(5):1261-9. PubMed ID: 3490493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(A)+RNA as a possible target for deoxyadenosine induced G1/G0 lymphotoxicity.
    Kefford RF; Fox RM; McCairns E; Fahey D; Muscat GE; Rowe PB
    Adv Exp Med Biol; 1984; 165 Pt B():339-44. PubMed ID: 6202120
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
    Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
    Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis.
    Traganos F; Gong J; Ardelt B; Darzynkiewicz Z
    J Cell Physiol; 1994 Mar; 158(3):535-44. PubMed ID: 8126077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
    Duan DS; Smith W; Sadée W; Cowan MJ
    Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased adenosine deaminase (ADA) activity and a shift from ADA-dependent to ADA-independent phases during T-cell activation: a paradox.
    Veit BC; Fishman M; Look T
    J Natl Cancer Inst; 1984 May; 72(5):1151-9. PubMed ID: 6609265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    Seto S; Carrera CJ; Wasson DB; Carson DA
    J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
    Matsumoto M; Weckbecker G; Cory JG
    Cancer Commun; 1990; 2(1):1-6. PubMed ID: 2369548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
    Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z
    Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.